These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 22404155

  • 21. Novel poly (ADP-ribose) polymerase inhibitor, AZD2281, enhances radiosensitivity of both normoxic and hypoxic esophageal squamous cancer cells.
    Zhan L, Qin Q, Lu J, Liu J, Zhu H, Yang X, Zhang C, Xu L, Liu Z, Cai J, Ma J, Dai S, Tao G, Cheng H, Sun X.
    Dis Esophagus; 2016 Apr; 29(3):215-23. PubMed ID: 25604309
    [Abstract] [Full Text] [Related]

  • 22. Role of poly(ADP-ribose) polymerase in cell-cycle checkpoint mechanisms following gamma-irradiation.
    Masutani M, Nozaki T, Wakabayashi K, Sugimura T.
    Biochimie; 1995 Apr; 77(6):462-5. PubMed ID: 7578430
    [Abstract] [Full Text] [Related]

  • 23. Radiosensitization by the poly(ADP-ribose) polymerase inhibitor 4-amino-1,8-naphthalimide is specific of the S phase of the cell cycle and involves arrest of DNA synthesis.
    Noël G, Godon C, Fernet M, Giocanti N, Mégnin-Chanet F, Favaudon V.
    Mol Cancer Ther; 2006 Mar; 5(3):564-74. PubMed ID: 16546970
    [Abstract] [Full Text] [Related]

  • 24. Poly(ADP-ribosyl)ation is required for p53-dependent signal transduction induced by radiation.
    Wang X, Ohnishi K, Takahashi A, Ohnishi T.
    Oncogene; 1998 Dec 03; 17(22):2819-25. PubMed ID: 9879988
    [Abstract] [Full Text] [Related]

  • 25. PARP-1 inhibition induces a late increase in the level of reactive oxygen species in cells after ionizing radiation.
    Cieślar-Pobuda A, Saenko Y, Rzeszowska-Wolny J.
    Mutat Res; 2012 Apr 01; 732(1-2):9-15. PubMed ID: 22321899
    [Abstract] [Full Text] [Related]

  • 26. Radiosensitization Effect of Talazoparib, a Parp Inhibitor, on Glioblastoma Stem Cells Exposed to Low and High Linear Energy Transfer Radiation.
    Lesueur P, Chevalier F, El-Habr EA, Junier MP, Chneiweiss H, Castera L, Müller E, Stefan D, Saintigny Y.
    Sci Rep; 2018 Feb 26; 8(1):3664. PubMed ID: 29483558
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. PARP-1 inhibition with or without ionizing radiation confers reactive oxygen species-mediated cytotoxicity preferentially to cancer cells with mutant TP53.
    Liu Q, Gheorghiu L, Drumm M, Clayman R, Eidelman A, Wszolek MF, Olumi A, Feldman A, Wang M, Marcar L, Citrin DE, Wu CL, Benes CH, Efstathiou JA, Willers H.
    Oncogene; 2018 May 26; 37(21):2793-2805. PubMed ID: 29511347
    [Abstract] [Full Text] [Related]

  • 29. BLM helicase inhibition synergizes with PARP inhibition to improve the radiosensitivity of olaparib resistant non-small cell lung cancer cells by inhibiting homologous recombination repair.
    Kong Y, Xu C, Sun X, Sun H, Zhao X, He N, Ji K, Wang Q, Du L, Wang J, Zhang M, Liu Y, Wang Y, Liu Q.
    Cancer Biol Med; 2021 Dec 01; 19(8):1150-71. PubMed ID: 34846107
    [Abstract] [Full Text] [Related]

  • 30. Efficacy of poly (ADP-ribose) polymerase inhibitor olaparib against head and neck cancer cells: Predictions of drug sensitivity based on PAR-p53-NF-κB interactions.
    Kwon M, Jang H, Kim EH, Roh JL.
    Cell Cycle; 2016 Nov 16; 15(22):3105-3114. PubMed ID: 27686740
    [Abstract] [Full Text] [Related]

  • 31. PARP inhibition sensitizes childhood high grade glioma, medulloblastoma and ependymoma to radiation.
    van Vuurden DG, Hulleman E, Meijer OL, Wedekind LE, Kool M, Witt H, Vandertop PW, Würdinger T, Noske DP, Kaspers GJ, Cloos J.
    Oncotarget; 2011 Dec 16; 2(12):984-96. PubMed ID: 22184287
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. PARP Inhibition Combined With Thoracic Irradiation Exacerbates Esophageal and Skin Toxicity in C57BL6 Mice.
    Lourenco LM, Jiang Y, Drobnitzky N, Green M, Cahill F, Patel A, Shanneik Y, Moore J, Ryan AJ.
    Int J Radiat Oncol Biol Phys; 2018 Mar 01; 100(3):767-775. PubMed ID: 29413287
    [Abstract] [Full Text] [Related]

  • 34. Rad51 Degradation: Role in Oncolytic Virus-Poly(ADP-Ribose) Polymerase Inhibitor Combination Therapy in Glioblastoma.
    Ning J, Wakimoto H, Peters C, Martuza RL, Rabkin SD.
    J Natl Cancer Inst; 2017 Mar 01; 109(3):1-13. PubMed ID: 28376211
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Replication-dependent radiosensitization of human glioma cells by inhibition of poly(ADP-Ribose) polymerase: mechanisms and therapeutic potential.
    Dungey FA, Löser DA, Chalmers AJ.
    Int J Radiat Oncol Biol Phys; 2008 Nov 15; 72(4):1188-97. PubMed ID: 18954712
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.